IRIS Accounts Production v24.3.0.553 SC515651 director 1.3.23 29.2.24 29.2.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC5156512023-02-28SC5156512024-02-29SC5156512023-03-012024-02-29SC5156512022-02-28SC5156512022-03-012023-02-28SC5156512023-02-28SC515651ns15:Scotland2023-03-012024-02-29SC515651ns14:PoundSterling2023-03-012024-02-29SC515651ns10:Director12023-03-012024-02-29SC515651ns10:PrivateLimitedCompanyLtd2023-03-012024-02-29SC515651ns10:SmallEntities2023-03-012024-02-29SC515651ns10:AuditExemptWithAccountantsReport2023-03-012024-02-29SC515651ns10:SmallCompaniesRegimeForDirectorsReport2023-03-012024-02-29SC515651ns10:SmallCompaniesRegimeForAccounts2023-03-012024-02-29SC515651ns10:FullAccounts2023-03-012024-02-29SC515651ns10:RegisteredOffice2023-03-012024-02-29SC515651ns5:CurrentFinancialInstruments2024-02-29SC515651ns5:CurrentFinancialInstruments2023-02-28SC515651ns5:Non-currentFinancialInstruments2024-02-29SC515651ns5:Non-currentFinancialInstruments2023-02-28SC515651ns5:ShareCapital2024-02-29SC515651ns5:ShareCapital2023-02-28SC515651ns5:CapitalRedemptionReserve2024-02-29SC515651ns5:CapitalRedemptionReserve2023-02-28SC515651ns5:RetainedEarningsAccumulatedLosses2024-02-29SC515651ns5:RetainedEarningsAccumulatedLosses2023-02-28SC515651ns5:PlantMachinery2023-03-012024-02-29SC515651ns5:PlantMachinery2023-02-28SC515651ns5:FurnitureFittings2023-02-28SC515651ns5:ComputerEquipment2023-02-28SC515651ns5:FurnitureFittings2023-03-012024-02-29SC515651ns5:ComputerEquipment2023-03-012024-02-29SC515651ns5:PlantMachinery2024-02-29SC515651ns5:FurnitureFittings2024-02-29SC515651ns5:ComputerEquipment2024-02-29SC515651ns5:PlantMachinery2023-02-28SC515651ns5:FurnitureFittings2023-02-28SC515651ns5:ComputerEquipment2023-02-28SC515651ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-02-29SC515651ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-02-28SC515651ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2024-02-29SC515651ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2023-02-28SC515651ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-02-29SC515651ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-02-28SC515651ns5:DeferredTaxation2023-02-28SC515651ns5:DeferredTaxation2023-03-012024-02-29SC515651ns5:DeferredTaxation2024-02-29SC515651ns5:RetainedEarningsAccumulatedLosses2023-02-28SC515651ns5:CapitalRedemptionReserve2023-02-28SC515651ns5:RetainedEarningsAccumulatedLosses2023-03-012024-02-29
REGISTERED NUMBER: SC515651 (Scotland)















Unaudited Financial Statements for the Year Ended 29 February 2024

for

Dr Liliana Limited

Dr Liliana Limited (Registered number: SC515651)






Contents of the Financial Statements
for the Year Ended 29 February 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Chartered Accountants' Report 8

Dr Liliana Limited

Company Information
for the Year Ended 29 February 2024







DIRECTOR: Dr L Ramirez Pena





REGISTERED OFFICE: 12a Castle Terrace
Edinburgh
EH1 2DP





REGISTERED NUMBER: SC515651 (Scotland)





ACCOUNTANTS: Key Professional Partnership Ltd
Unit 3
Morris Park
37 Rosyth Road
Glasgow
G5 0YE

Dr Liliana Limited (Registered number: SC515651)

Balance Sheet
29 February 2024

29.2.24 28.2.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 19,723 10,953

CURRENT ASSETS
Stocks 5 8,430 15,000
Debtors 6 15,896 17,175
Cash at bank and in hand 142,409 203,690
166,735 235,865
CREDITORS
Amounts falling due within one year 7 97,022 100,777
NET CURRENT ASSETS 69,713 135,088
TOTAL ASSETS LESS CURRENT
LIABILITIES

89,436

146,041

CREDITORS
Amounts falling due after more than one
year

8

(13,432

)

(23,487

)

PROVISIONS FOR LIABILITIES 9 (4,872 ) (2,652 )
NET ASSETS 71,132 119,902

CAPITAL AND RESERVES
Called up share capital 70 70
Capital redemption reserve 10 30 30
Retained earnings 10 71,032 119,802
71,132 119,902

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 29 February 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 29 February 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Dr Liliana Limited (Registered number: SC515651)

Balance Sheet - continued
29 February 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 19 November 2024 and were signed by:





Dr L Ramirez Pena - Director


Dr Liliana Limited (Registered number: SC515651)

Notes to the Financial Statements
for the Year Ended 29 February 2024

1. STATUTORY INFORMATION

Dr Liliana Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on cost

Tangible fixed assets are stated at cost (or deemed cost) less accumulated depreciation and accumulated impairment losses.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
Basic financial instruments are recognised as follows:

(i) Debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using effective interest method less any impairment.

(ii) Cash and cash equivalents
Cash and cash equivalents include cash at bank and in hand.

Cash and cash equivalents are shown net of bank overdrafts, which are included as current borrowings in liabilities on the balance sheet.

(iii) Creditors
Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


Dr Liliana Limited (Registered number: SC515651)

Notes to the Financial Statements - continued
for the Year Ended 29 February 2024

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 8 (2023 - 7 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£    £    £    £   
COST
At 1 March 2023 26,400 6,708 2,128 35,236
Additions 654 8,395 7,961 17,010
At 29 February 2024 27,054 15,103 10,089 52,246
DEPRECIATION
At 1 March 2023 15,637 6,708 1,938 24,283
Charge for year 4,063 2,099 2,078 8,240
At 29 February 2024 19,700 8,807 4,016 32,523
NET BOOK VALUE
At 29 February 2024 7,354 6,296 6,073 19,723
At 28 February 2023 10,763 - 190 10,953

Dr Liliana Limited (Registered number: SC515651)

Notes to the Financial Statements - continued
for the Year Ended 29 February 2024

5. STOCKS
29.2.24 28.2.23
£    £   
Stocks 8,430 15,000

6. DEBTORS
29.2.24 28.2.23
£    £   
Amounts falling due within one year:
Velasco Herce Ltd - IC - 9,179
Prepayments 9,146 1,246
9,146 10,425

Amounts falling due after more than one year:
Other debtors 6,750 6,750

Aggregate amounts 15,896 17,175

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
29.2.24 28.2.23
£    £   
Bank loans and overdrafts 10,067 10,033
Trade creditors 23,722 16,881
Tax 52,568 31,144
Social security and other taxes 1,783 6,418
Capital On Tap 640 20,305
Deposits/POA 3,664 13,666
Gift Vouchers 1,852 408
Pension Fund 325 (78 )
Directors' current accounts 1 -
Accrued expenses 2,400 2,000
97,022 100,777

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
29.2.24 28.2.23
£    £   
Bank loans - 1-2 years 10,090 10,059
Bank loans - 2-5 years 3,342 13,428
13,432 23,487

9. PROVISIONS FOR LIABILITIES
29.2.24 28.2.23
£    £   
Deferred tax 4,872 2,652

Dr Liliana Limited (Registered number: SC515651)

Notes to the Financial Statements - continued
for the Year Ended 29 February 2024

9. PROVISIONS FOR LIABILITIES - continued

Deferred
tax
£   
Balance at 1 March 2023 2,652
Charge to Profit and Loss Account during year 2,220
Balance at 29 February 2024 4,872

10. RESERVES
Capital
Retained redemption
earnings reserve Totals
£    £    £   

At 1 March 2023 119,802 30 119,832
Profit for the year 168,914 - 168,914
Dividends (217,684 ) - (217,684 )
At 29 February 2024 71,032 30 71,062

11. ULTIMATE CONTROLLING PARTY

Velasco Herce Ltd hold 100% of the ordinary share capital of the company. The registered office and principal place of business is 4 Seton Place, Edinburgh, Scotland, UK, EH9 2JT.

Chartered Accountants' Report to the Director
on the Unaudited Financial Statements of
Dr Liliana Limited

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Dr Liliana Limited for the year ended 29 February 2024 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of ICAS, we are subject to its ethical and other professional requirements which are detailed at http://www.icas.com/accountspreparationguidance.

This report is made solely to the director of Dr Liliana Limited in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Dr Liliana Limited and state those matters that we have agreed to state to the director of Dr Liliana Limited in this report in accordance with the requirements of ICAS as detailed at http://www.icas.com/accountspreparationguidance. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and its director for our work or for this report.

It is your duty to ensure that Dr Liliana Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Dr Liliana Limited. You consider that Dr Liliana Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Dr Liliana Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Key Professional Partnership Ltd
Unit 3
Morris Park
37 Rosyth Road
Glasgow
G5 0YE


19 November 2024